PITTSBURGH, June 12th, 2014 — Gateway Analytical announced today that they will be presenting a poster session that focused on using Raman Imaging for chemically specific characterization of Combination Dry Powder Inhalers at the Sixteenth International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS®-16), June 16-19th in Prague, Czech Republic.
PITTSBURGH, June 2nd, 2014 — Gateway Analytical announced today that they will be exhibiting at the 3rd Annual ISPE-FDA CGMP Conference in Baltimore, Maryland, June 2-4th. The ISPE-FDA CGMP Conference promotes and presents the latest topics in different areas of the pharmaceutical industry including quality, innovation, technology and regulatory affairs. At this event, attendees and exhibitors benefit from having direct interaction and discussions with the FDA and leading experts in the areas of drug development and manufacturing.
PITTSBURGH, April 24th, 2014 — Gateway Analytical announced today that they will be exhibiting and presenting at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo, Puerto Rico, May 4-8. RDD is an international conference that features in-depth presentations and discussions focused on the latest development in respiratory drug delivery science, in addition to industry networking. During the conference Gateway will be promoting their unique Raman chemical imaging services that provide drug developers with truly chemically specific particle characterization. This chemical specificity is the key to understanding the extend of agglomerations in orally inhaled drug products (OINDPs), which is critical for safety, stability and FDA submission.
PITTSBURGH, March, 11th, 2014 — Gateway Analytical announced today that they have collaborated with researchers from the Division of Pharmaceutical Analysis at the Food and Drug Administration’s Drug Evaluation and Research Center (FDA/CDER) to present new findings on temperature-mediated agglomeration assessment in Orally Inhaled and Nasal Drug Products (OINDP’s) at the upcoming Respiratory Drug Delivery (RDD) conference in Fajardo, Puerto Rico, May 4-8, 2014.
PITTSBURGH, January, 21 2014 — Gateway Analytical announced today that they have acquired the RapID SPE-ls raman.ID + metal.ID® system, the latest technology in automated particle identification. This acquisition enhances existing analytical service offerings to the pharmaceutical and materials science industries, and makes Gateway one of only two analytical service laboratories in the United States that can offer this advanced technology.
PITTSBURGH, PA – Gateway Analytical announced today that the company received its 17025:2005 accreditation from the American Association for Laboratory Accreditation (A2LA). This accreditation is another illustration of Gateway’s commitment to quality and technical expertise, and focuses on material science and industrial forensics laboratory testing.